Biden plan to expand obesity drug coverage is rejected

The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions of Americans access the medications.

Leave A Comment

Your email address will not be published. Required fields are marked *